Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Bev Incledon"'
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 1, Pp 132-142 (2024)
Abstract Delayed‐release and extended‐release methylphenidate hydrochloride (JORNAY PM®) is a novel capsule formulation of methylphenidate hydrochloride, used to treat attention deficit hyperactivity disorder in patients 6 years and older. In th
Externí odkaz:
https://doaj.org/article/52b4d8aecf41422caf7dc7daf960fbf8
Autor:
Norberto J. DeSousa, Cassandra L. Uchida, Floyd R. Sallee, Paul Hammerness, Jeffrey H. Newcorn, Bev Incledon, Timothy E. Wilens, Stephen V. Faraone, Steven R. Pliszka
Publikováno v:
Journal of Attention Disorders
Objective: The Before School Functioning Questionnaire and Parent Rating of Evening and Morning Behavior–Revised assess early morning (BSFQ, PREMB-R AM subscale) and late afternoon/evening (PREMB-R PM subscale) functional impairment in children wit
Autor:
Stephen V. Faraone, Norberto J. DeSousa, Tayyaba F Khan, Stephanie Rhoten, Frank A. Lopez, Helen Doll, Bev Incledon, Hannah Lewis, Floyd R. Sallee, Jeffrey H. Newcorn
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: Inadequately controlled symptoms and associated impaired functioning have a significant negative impact on caregivers of children with attention-deficit/hyperactivity disorder (ADHD). This study aimed to assess the impact of evening-dosed
Publikováno v:
Clinical Therapeutics. 42:2332-2340
Purpose HLD200 is the first evening-dosed, delayed-release and extended-release methylphenidate (DR/ER-MPH) designed to delay initial release of MPH and provide treatment effects throughout the day and into the evening for individuals with attention-
Autor:
Floyd R. Sallee, Mary Ann McDonnell, Andrea Marraffino, Norberto J. DeSousa, Bev Incledon, Sharon B. Wigal, Matthew Brams, John M. Turnbow, Ann C. Childress, Andrew J. Cutler
Publikováno v:
Journal of Child and Adolescent Psychopharmacology
Objectives: HLD200, a once-daily, evening-dosed, delayed-release and extended-release methylphenidate (DR/ER-MPH), was designed to provide therapeutic effect beginning upon awakening and lasting into the evening. This pivotal, randomized, double-blin
Publikováno v:
Innov Clin Neurosci
OBJECTIVE: Extended-release methylphenidate (ER-MPH) formulations used to treat attention deficit hyperactivity disorder (ADHD) have complex pharmacokinetic (PK) profiles, resulting from differing ratios of immediate-release and extended-release comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::003f8a856659a643b741b2465001c59a
https://europepmc.org/articles/PMC9507140/
https://europepmc.org/articles/PMC9507140/
Autor:
Bev Incledon, Chantal Incledon, Roberto Gomeni, Cassandra L. Uchida, Amy Morris, Kim Perry, Jill Kapuscinski
Publikováno v:
Clinical pharmacology in drug development. 11(8)
Most stimulants used to treat attention-deficit/hyperactivity disorder are administered in the morning and absorbed in the upper gastrointestinal tract. DR/ER-MPH (formerly HLD200), an evening-dosed delayed-release and extended-release methylphenidat
Autor:
Lewis E. Warrington, Norberto J. DeSousa, Andrew J. Cutler, Floyd R. Sallee, Michelle D. Po, Ann C. Childress, Bev Incledon
Publikováno v:
The Journal of clinical psychiatry. 82(4)
Objective: Delayed-release and extended-release methylphenidate (DR/ER-MPH), the first stimulant predicted to be absorbed primarily in the colon, demonstrated significant improvements in attention-deficit/hyperactivity disorder (ADHD) symptoms and fu
Publikováno v:
Journal of Clinical Psychopharmacology
Supplemental digital content is available in the text.
Purpose/Background HLD200 is an evening-dosed, delayed-release and extended-release methylphenidate (DR/ER-MPH) that provides a consistent delay in initial drug release to target onset of th
Purpose/Background HLD200 is an evening-dosed, delayed-release and extended-release methylphenidate (DR/ER-MPH) that provides a consistent delay in initial drug release to target onset of th
Autor:
Stephen V. Faraone, Marina Komolova, Norberto J. DeSousa, Timothy E. Wilens, F. Randy Sallee, Bev Incledon
Publikováno v:
The Journal of Clinical Psychiatry. 81
OBJECTIVE Children with attention-deficit/hyperactivity disorder (ADHD) frequently manifest behavioral difficulties in the morning prior to school and in the afternoons and evenings. We sought to establish norms for 2 time-specific measures of functi